Purpose
|
Decitabine is indicated for treatment of patients with myelodysplastic syndrome (MDS). It is a chemical analogue of cytidine, a nucleoside present in DNA and RNA. Cells in the presence of Decitabine incorporate it into DNA during replication and RNA during transcription. The incorporation of Decitabine into DNA or RNA inhibits methyltransferase thereby causing demethylation in that sequence. This adversely affects the way that cell regulatory proteins are able to bind to the DNA/RNA substrate.
|
Characteristics
|
Tradename: DAUNOXOME Source of Compound: Streptomyces peucetius, FI-6339, NDC-0082-4155, RP-13057 Target: DNA Methyltransferase inhibitor Receptor: DNA Methyltransferase Status: USAN, INN, BAN, JAN
|
Purification
|
All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
|
Purity
|
99.50?%
|
Formula
|
C8H12N4O4
|
Solubility
|
DMSO 45 mg/mL,Water 10 mg/mL
|